Li Y, Liang Y, Ye P, Chen G, et al. Effectiveness and safety of camrelizumab plus apatinib in treating recurrent/metastatic nasopharyngeal carcinoma: a single-arm meta-analysis. Eur Arch Otorhinolaryngol 2025 May 31. doi: 10.1007/s00405-025-09482.
PMID: 40450144